“Two-phase”的搜索结果，显示 211-220 项，共有 4316 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Phase 2 Trial Of Voyager V1 In Combination With Cemiplimab In Cancer Patients. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Phase 2 Trial Of Voyager V1 In Combination With Cemiplimab In Cancer Patients. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of ...

3. 视神经脊髓炎- 症状与病因- 妙佑医疗国际

   Cree BAC, et al. Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-Momentum): A double-blind, randomized placebo-controlled phase 2/3 ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Phase 1/2 Study Of MRTX1719 In Solid Tumors With MTAP Deletion. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Phase 2 Trial Of Voyager V1 In Combination With Cemiplimab In Cancer Patients. Jacksonville, Fla., Scottsdale/Phoenix, Ariz., Rochester, Minn. The purpose of ...

6. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... 2 prior lines of therapy. ... The purpose of this study is to assess outcomes, satisfaction and aesthetics of two ... This phase II trial studies how well ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary objective of Part 1 of this study is to define the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of CC-220 in ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Phase 2 Trial Of Voyager V1 In Combination With Cemiplimab In Cancer Patients. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of ...

10. 血液科- 临床试验- 妙佑医疗国际

    This is a Phase 2 global, multi-center, open-label study to assess the ... two prior lines of therapies. The study has 2 Modules: Module 1 for FL and ...